2131173-58-3

AB-CHMINACA (Item No. 15434) is a synthetic cannabinoid (CB) that is an analog of AB-FUBINACA (Item No. 14039), a potent agonist of the central CB1 receptor (Ki = 0.9 nM).1,2 AB-CHMINACA metabolite M3A is an expected dihydroxylated metabolite produced during metabolism of AB-CHMINACA in the liver. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.WARNING This product is not for human or veterinary use.

[1] N. UCHIYAMA. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products[J]. Forensic Toxicology, 2012, 31 1: 93-100. DOI: 10.1007/s11419-012-0171-4
[2] KIKELJ D. From Indazole Derivatives[C]. 1900: 0. DOI: 10.1055/sos-sd-016-00861